Strut Health Review vs PlexusDx (2026): Oral GLP-1 Lozenges, Pricing, FDA Warning Letter | PlexusDx

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

If you searched "Strut Health reviews" you're in the final pre-decision window: the price looks aggressive, the oral lozenge is unusual, and you want to know whether the platform actually holds up before you hand over a credit card. The short version: Strut Health is a real Dallas-based digital health company founded by Simal Patel, MD, that prescribes compounded semaglutide and tirzepatide through U.S.-licensed compounding pharmacies. It's best known for a sublingual oral semaglutide lozenge that lists between $99/mo and $149/mo across different pages of its own site. It also received a direct FDA warning letter on February 20, 2026 about marketing claims, holds a D+ BBB rating, and customer complaints cluster around subscription cancellation friction rather than medication quality. This review walks the actual cost math, the compounded-vs-FDA-approved question, the safety profile, and where PlexusDx Microdose GLP-1 Protocol, Semaglutide Injection, and Tirzepatide Injection sit relative to Strut — because the choice isn't really about which company is "better," it's about medication source, oversight model, total annualized cost, and whether genetics inform your dose before week one.

Strut Health at a glance — what we verified

Strut Health is a cash-pay telehealth platform that prescribes four compounded GLP-1 formats: oral semaglutide lozenges (the headline format) at $99–$149/mo depending on which Strut page you read and whether you opt into auto-refill, injectable semaglutide at $149–$289/mo, oral tirzepatide lozenges around $239/mo, and injectable tirzepatide around $325/mo. Consultation and shipping are advertised as included, contracts are month-to-month, and insurance is not accepted. The company has 750+ Trustpilot reviews with a 3.3 average and a D+ BBB rating, and its physicians are licensed across all 50 states (with state-specific compounded shipping restrictions noted for some products). The pricing inconsistency across Strut's own pages is real and worth confirming before your first order ships — it's the most-cited friction point in our scrape.

The 2026 FDA warning letter — what changed

On February 20, 2026, the FDA issued Strut Health a direct warning letter regarding marketing claims on its website. A warning letter is a formal compliance notice, not a recall or a closure order. It does not mean Strut's compounded medications are unsafe to take, and it does not mean the company is shutting down. It does mean the FDA flagged specific website language for revision and gave Strut a deadline to respond. For prospective patients, the practical implication is straightforward: marketing copy you read on Strut today may differ materially from copy you read in January 2026, and any "FDA-approved"-adjacent language about compounded products should be treated skeptically across every platform — not just Strut. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products, on Strut, on any other compounding telehealth platform, or on the PlexusDx Semaglutide Injection protocol. The active pharmaceutical ingredients are the same as those in Wegovy, Ozempic, Zepbound, and Mounjaro; the regulatory framework is different.

What you actually get with Strut — four formats compared

Strut's four compounded options break down by route and active ingredient. Oral semaglutide lozenge is the format Strut is best known for — a daily sublingual lozenge that dissolves under the tongue, marketed as needle-free, listed at $99–$149/mo. Injectable semaglutide is a weekly subcutaneous injection from a multi-dose vial, $149–$289/mo. Oral tirzepatide lozenge is a daily sublingual at roughly $239/mo. Injectable tirzepatide is a weekly subcutaneous injection around $325/mo. Every option includes provider consult and shipping per Strut's published pages. PlexusDx Weight Management Protocols cover similar territory but with slightly different format choices: Microdose GLP-1 Protocol at $129/mo flat (compounded GLP-1 across capsule, troche, lozenge, sublingual variants), Semaglutide Oral from $249/mo (3mg–24mg daily across six dose levels), Semaglutide Injection at $149/mo (0.25mg–2.0mg weekly across five dose levels), Tirzepatide Injection at $249/mo (2.5mg–15mg weekly across six dose levels), Tirzepatide Oral at $279/mo (5mg–25mg daily across seven dose levels), and GLP-Squared dual-compound at $249/mo. The clinical question to ask either platform: which delivery format and dose ladder fits your tolerability profile and genetics, not just your needle preference.

How much does Strut really cost — the annualized math

If you take Strut's lowest oral lozenge price ($99/mo with auto-refill) at face value and stay on it for a year, that's $1,188/year. If you land on the $149/mo oral lozenge price (the higher number we saw on Strut's own pages), that's $1,788/year. Injectable semaglutide at the midpoint ($219/mo) annualizes to $2,628; injectable tirzepatide at $325/mo annualizes to $3,900. Compare to PlexusDx: Microdose GLP-1 Protocol at $129/mo flat is $1,548/year, Semaglutide Injection at $149/mo is $2,148–$2,748/year, Tirzepatide Injection at $249/mo is $2,748–$3,708/year, and GLP-Squared at $249/mo is $2,148–$3,900/year. Add the Precision Peptide Genetic Test as a $99 add-on after month one and the genetic-baseline-included totals stay competitive. Strut is genuinely cheap at the entry-tier oral lozenge if you can hit the $99/mo auto-refill price; PlexusDx Microdose at $129/mo is in the same neighborhood and bundles in protocol-specific dose escalation across four delivery variants. At the injectable tier, PlexusDx pricing is below or equal to Strut's verified injectable ranges across both semaglutide and tirzepatide.

What real customer reviews actually say about Strut

The 750+ Trustpilot reviews and BBB complaints split cleanly along two lines. Positive reviews praise the responsiveness of Strut's physicians, the convenience of the oral lozenge format for needle-averse patients, and shipping that typically arrives within 5–7 business days. Negative reviews concentrate on subscription friction: login and password loops that prevent online cancellation, unexpected auto-refill charges, and occasional shipping delays attributed to partner pharmacies. The medical care itself and the medication quality generally receive positive marks. The cancellation friction is the most actionable concern: Strut requires emailing care@struthealth.com or messaging your physician with 48 hours' notice before the next refill, and refunds are generally not available after pharmacy processing or shipment. If you sign up, set a reminder before your billing date.

Compounded vs FDA-approved — the substantive medication difference

Strut's lozenges and injectables are compounded — prepared by licensed compounding pharmacies under U.S. compounding regulations, using the same active pharmaceutical ingredients (semaglutide, tirzepatide) found in FDA-approved branded drugs. They are not FDA-approved finished drug products. FDA-approved branded options for the same indications are Wegovy and Ozempic (semaglutide, Novo Nordisk), Mounjaro and Zepbound (tirzepatide, Eli Lilly), and Rybelsus (oral semaglutide tablet, Novo Nordisk). Importantly, Strut's oral semaglutide lozenge is not the same product as Rybelsus — Rybelsus is an FDA-approved swallowed tablet absorbed through the GI tract; Strut's lozenge is a compounded sublingual that dissolves under the tongue. Different format, different absorption route, different regulatory status. PlexusDx Semaglutide Oral and Microdose GLP-1 Protocol sit in the same compounded-not-FDA-approved category as Strut's lozenges — the same regulatory caveats apply.

Safety, side effects, and clinical oversight

The FDA-labeled side-effect profile for GLP-1 receptor agonists and the GIP/GLP-1 dual agonist tirzepatide is well-characterized: nausea, vomiting, diarrhea, constipation, abdominal pain, and headache are common; pancreatitis, gallbladder disease, and acute kidney injury are less common but documented. The boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies — not just one or the other. Anyone with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not take either compound, compounded or branded. Strut's physicians screen for these contraindications during the consult; PlexusDx clinicians do the same. The differentiator is what happens after the screen: PlexusDx pairs the protocol with the optional Precision Peptide Genetic Test so the prescribing clinician can review GIPR rs1800437, GLP1R, FTO, MC4R, and TCF7L2 variants before titration. Strut starts from population-average titration and adjusts based on subjective tolerability over the first 8–12 weeks.

Strut vs PlexusDx — a four-question decision frame

Question 1: Are you needle-averse and committed to a daily oral format? Strut's oral lozenge and the PlexusDx Microdose GLP-1 Protocol (which includes lozenge and sublingual variants) are both viable; pricing is comparable at the entry tier. Question 2: Is total annualized cost the dominant factor and you can hit Strut's $99/mo auto-refill price? Strut wins on raw price for the lozenge specifically. Question 3: Do you want frictionless cancellation, a higher BBB rating, and no recent FDA marketing-letter overhang? PlexusDx's cash-pay, no-membership structure addresses the first; the other two factors are platform-level concerns Strut customers raise. Question 4: Do you want a genetic baseline informing your dose and titration before the first injection or lozenge? PlexusDx is the only option in this comparison that includes the Precision Peptide Genetic Test as part of the protocol pathway — $298 standalone, or $99 as an add-on after your first month on any protocol.

Frequently asked questions

Is Strut Health legit?

Yes. Strut Health is a real Dallas-based digital healthcare company founded by Simal Patel, MD, that works with U.S.-licensed physicians and U.S.-licensed compounding pharmacies. It has 750+ Trustpilot reviews, a D+ BBB rating, and received an FDA warning letter on February 20, 2026 about marketing claims. Legit doesn't mean problem-free — cancellation friction and pricing inconsistency across its own pages are documented complaints worth weighing.

Is Strut's oral semaglutide the same as Rybelsus?

No. Rybelsus is an FDA-approved swallowed semaglutide tablet manufactured by Novo Nordisk and absorbed through the GI tract. Strut's oral semaglutide is a compounded sublingual lozenge that dissolves under the tongue. Different format, different absorption route, different regulatory status. PlexusDx Semaglutide Oral is also a compounded oral product, not Rybelsus.

How much does Strut Health really cost per month?

Across Strut's own pages we found $99–$149/mo for the oral semaglutide lozenge (the lower number requires auto-refill enrollment), $149–$289/mo for injectable semaglutide, around $239/mo for oral tirzepatide, and around $325/mo for injectable tirzepatide. Confirm your exact price before your first order ships. PlexusDx Microdose GLP-1 Protocol is $129/mo flat as a comparison entry point.

Does Strut sell FDA-approved Wegovy, Ozempic, Zepbound, or Mounjaro?

No. Strut sells compounded versions of semaglutide and tirzepatide — the same active pharmaceutical ingredients as those branded drugs, but prepared by licensed compounding pharmacies rather than Novo Nordisk or Eli Lilly. Compounded products are not FDA-approved finished drugs. The same caveat applies to PlexusDx's compounded protocols; if you specifically need branded medication, neither platform is the right path.

Can you cancel Strut Health subscriptions easily?

Cancellation requires emailing care@struthealth.com or messaging your physician with at least 48 hours' notice before your next refill. There are no cancellation fees, but refunds are generally not available after pharmacy processing or shipment. The most-cited customer complaint is login and password friction that complicates online cancellation. PlexusDx is also cash-pay with no membership lock-in.

Is compounded semaglutide safe to take?

The active ingredient is the same as in FDA-approved Wegovy and Ozempic, but the FDA notes that compounded products do not undergo premarket review and may vary in manufacturing oversight, storage, and quality control across pharmacies. Choosing a platform that uses U.S.-licensed compounding pharmacies reduces but does not eliminate this risk. The boxed warning for thyroid C-cell tumors applies to compounded semaglutide and tirzepatide identically to the branded versions.

Should I choose Strut Health or PlexusDx?

Choose Strut if your priority is the lowest-priced compounded oral lozenge and you can hit the $99/mo auto-refill tier. Choose PlexusDx if you want a genetic baseline informing dose and titration before week one (via the Precision Peptide Genetic Test at $99 as a post-month-one add-on), six protocols across four mechanism classes, all-inclusive pricing from $129/mo on Microdose GLP-1 Protocol, and a no-membership cash-pay structure across all 50 states.

Related reading on PlexusDx

Related reading on PlexusDx: GLP-1 Cost, Semaglutide Cost, Cheapest GLP-1, Oral Semaglutide vs Injection.

Disclaimer: This article is educational and is not medical advice. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols. Pricing for Strut Health is based on the provider's published rates as of April 2026; actual costs may vary by state, plan, and individual eligibility. PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols. Discuss any GLP-1 medication decision with a licensed clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.